Skip to main content
Medios AG logo

Medios AG — Investor Relations & Filings

Ticker · ILM1 ISIN · DE000A1MMCC8 LEI · 391200Z7Z09IHDBT2L23 F Manufacturing
Open in API
Filings indexed 458 across all filing types
Latest filing 2024-03-18 M&A Activity
Country DE Germany
Listing F ILM1

About Medios AG

https://medios.ag/en/

Medios AG is a specialty pharmaceutical company focused on providing solutions for complex and rare diseases. The company's core business encompasses two main segments: the wholesale distribution of specialty pharma drugs and the manufacturing of patient-specific therapies. The manufacturing division compounds personalized medications, such as sterile infusions, for individual patients. As a comprehensive partner, Medios covers critical aspects of the supply chain for specialized pharmacies, medical practitioners, and pharmaceutical companies. The company is also dedicated to advancing individualized medicine by pioneering biotechnological precision medicine and advanced therapies to provide patients with innovative treatments.

Recent filings

Filing Released Lang Actions
Medios acquires Dutch market leader in pharmaceutical compounding services
M&A Activity Classification · 99% confidence The document is a news release announcing the acquisition of Ceban Pharmaceuticals by Medios AG. It contains keywords like 'Mergers & Acquisitions/Expansion', details of the transaction (purchase price, share issuance), preliminary financial figures for 2023, and new guidance for 2024/2025. This type of announcement, detailing a significant corporate transaction (M&A), fits best under the 'Merger/Takeover Activity' category, which corresponds to the TAR code. Although it contains financial updates, the primary driver and subject is the M&A event.
2024-03-18 English
Medios acquires Dutch market leader in pharmaceutical compounding services
M&A Activity Classification · 99% confidence The document is an 'Ad-hoc' announcement dated March 18, 2024, disclosing an 'Inside information acc. to Article 17 MAR'. The core content details the acquisition of Ceban Pharmaceuticals B.V. by Medios AG, including purchase price, financing, and updated FY 2024 revenue/EBITDA guidance. This announcement concerns a significant corporate action (Mergers & Acquisitions) and the resulting financial impact. It is not a full Annual Report (10-K), an Earnings Release (ER) focusing only on period results, or a standard regulatory filing (RNS) fallback. It most closely aligns with an announcement regarding a major corporate transaction, which falls under the scope of M&A Activity (TAR) or potentially Capital/Financing Update (CAP) due to the share issuance and credit facility. However, since the primary event is the acquisition itself, TAR (Merger Proposals or Takeover Bids) is the most appropriate fit for M&A news, even though it's an acquisition rather than a bid. Given the options, TAR captures the essence of the transaction announcement.
2024-03-18 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections detailing 'Notification of Major Holdings' under German Securities Trading Act (WpHG) regulations. It reports changes in the percentage of voting rights held by an individual (Marcel Jo Maschmeyer) and an associated entity (Paladin Asset Management), crossing specific thresholds. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels.
2024-02-14 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' by Allianz Global Investors GmbH in Medios AG. It specifies the date the threshold was crossed (29 Jan 2024) and details the change in the percentage of voting rights (from 4.99% to 2.94%). This content directly corresponds to regulatory filings concerning changes in significant share ownership, which maps precisely to the 'Major Shareholding Notification' category (MRQ). Although the header mentions 'Voting Rights Announcements', the core content is the change in major holding percentage.
2024-02-02 English
Medios AG: Supervisory Board extends contracts with members of the Executive Board Mi-Young Miehler and Christoph Prueit
Board/Management Information Classification · 99% confidence The document is a press release announcing that the Supervisory Board of Medios AG has extended the contracts of two Executive Board members (Mi-Young Miehler and Christoph Prußeit). This action directly relates to changes in senior management personnel and their tenure. According to the definitions, 'Board/Management Information (Code: MANG)' covers the 'Announcement of changes in the company's board of directors or senior management.' Although the document is distributed via EQS News (suggesting RNS), the specific content is a management announcement, making MANG the most precise classification. The document is not a full financial report (10-K, IR) or a general regulatory filing fallback (RNS) because the subject matter is highly specific to management appointments/extensions.
2024-02-01 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections detailing the 'Notification of Major Holdings' according to German securities law (WpHG). It reports changes in voting rights percentages (crossing thresholds) held by an individual and an associated entity (Paladin Asset Management). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels. Although the document mentions 'Voting Rights Announcements' in the header, the content is a formal notification of a change in shareholding percentage crossing a threshold (from 4.95% to 5.29%), which aligns perfectly with the definition for Major Shareholding Notification (MRQ). It is not an AGM result (DVA), nor a general regulatory filing (RNS), as MRQ is a more specific category for this type of disclosure.
2023-12-21 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.